Interaction between dyslipidaemia, oxidative stress and inflammatory response in patients with angiographically proven coronary artery disease

Cardiovascular Journal of Africa

Volumn 23, Issue 1, 2012, Pages 23-27

  Tayal, D ^a   Goswami, B ^a   Tyagi, S ^a   Chaudhary, M ^a   Mallika, V ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

Apolipoprotein B; Coronary artery disease; Ferritin; Nitric oxide

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; FERRITIN; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOGENESIS; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; CORONARY ANGIOGRAPHY; RISK FACTOR;

CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DYSLIPIDEMIAS; HUMANS; OXIDATIVE STRESS; RISK FACTORS;

EID: 84857329655     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2010-092     Document Type: Article

References (37)

1. Gaziano TA, Reddy KS, Paccaud F. Cardiovascular disease. In: Jamison DT, Breman JG, Measham AR (eds). Disease Control Priorities in the Developing World. Oxford: Oxford University Press, 2006: 645-662.
2. Reddy KS. Rising burden of cardiovascular diseases in India. In: Sethi KK (ed). Coronary Artery Disease in Indians: A Global Prospective. Mumbai: Cardiology Society of India, 1998: 63-72.
3. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143. (Pubitemid 34212626)
4. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndrome. Am J Cardiol 2001; 88(Suppl): 10K-15K. (Pubitemid 33016744)
5. Klipstein-Grobusch K, Koster JF, Grobbee DE, Lindemans J, Boeing H, Hofman A, Witteman JCM. Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam study. Am J Clin Nutr 1999; 69(6): 1231-1236. (Pubitemid 29252058)
6. Baykan M, Celik U, Orem A, Malkoc M, Erdol C, Baykan EC, et al. Iron status and its relationship with lipid peroxidation in patients with acute myocardial infarction. Acta Cardiol 2001; 56: 277-281. (Pubitemid 32964166)
7. Wolff B, Völzke H, Lüdemann J, Robinson D, Vogelgesang D, Staudt A, et al. Association between high serum ferritin levels and carotid atherosclerosis in the study of health in Pomerania (SHIP). Stroke 2004; 35: 453-457. (Pubitemid 38174429)
8. Haidari M, Javadi E, Sanati A, Hajilooi M, Ghanbili J. Association of increased ferritin with premature coronary stenosis in men. Clin Chem 2001; 47(9): 1666-1672. (Pubitemid 32781581)
9. Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. A Rev Physiol 1995; 57: 737-769.
10. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 40: C1424-C1437.
11. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995; 15: 551-561.
12. Mathew B, Johnson GJ, Lancaster JR. Quantitation of nitrate and nitrite in extracellular fluid. Methods Enzymol 1996; 268: 237-245.
13. Friewald WT, Levy RL, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
14. Hattori Y, Suzuki M, Tsushima M, Yoshida M, Tokunaga Y, Wang Y, et al. Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL. Atherosclerosis 1998; 138(2): 289-299. (Pubitemid 28313513)
15. Murray CJ, Lopez AD. Global mortality, disability and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 49: 1498-1504. (Pubitemid 27216360)
16. Achari V, Thakur AK. Association of major modifiable risk factors among patients with CAD - a retrospective analysis. J Assoc Phys India 2004; 52: 103-108. (Pubitemid 44194608)
17. Mckeigne PM, Miller GJ, Marmot MG. Coronary artery disease in south Asians overseas: a review. J Clin Epidemiol 1989; 41: 597-598.
18. Enas EA, Senthikumar A. Coronary artery disease in Asian Indians. An update and review. Internet J Cardiol 2001; 1: 1-42.
19. Yusuf S, Ounpuu S, Anand S. Global burden of cardiovascular disease: A review of evidence. In: Sethi KK (ed). Coronary Artery Disease in Indians: A Global Perspective. Mumbai: Cardiological Society of India, 1998: 11-25.
20. Enas EA, Yusuf S, Mehta J. Prevalence of coronary artery disease in Asian Indians. Am J Cardiol 1992; 70: 945-949.
21. Wood D. Established and emerging cardiovascular risk factors. Am Heart J 2001; 141: S49-57. (Pubitemid 32128719)
22. Alexander RW. Inflammation and coronary heart disease. N Engl J Med 1994; 331: 468-469.
23. McGovern PG, Pankow JS, Shahar E for the Minnesota Heart survey investigations. Recent trends in acute coronary heart disease mortality, morbidity, medical care and risk factors. N Engl J Med 1996; 334: 884-890. (Pubitemid 26107346)
24. Soydinç S, Çelik A, Demiryürek S, Davutoǧlu V, Tarakçioǧlu M, Aksoy M. The relationnship between oxidative stress, nitric oxide, and coronary artery disease. Eur J Gen Med 2007; 4(2): 62-66. (Pubitemid 351459405)
25. Chen J, Kuhlencordt P, Urano F, Ichinose H, Astern J, Huang PL. Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice. Arterioscler Thromb Vasc Biol 2003; 23: 97-103. (Pubitemid 36091632)
26. Pantopoulos K, Hentze MW. Nitric oxide signaling to iron regulatory protein: Direct control of ferritin mRNA translation and transferring receptor mRNA stability in transfected fibroblasts. Proc Natl Acad Sci 1995; 92: 1267-1271.
27. Cook S. Coronary artery disease, nitric oxide and oxidative stress: the 'Yin-Yang' effect - a Chinese concept for a worldwide pandemic. Swiss Medical Weekly 2006; 136: 103-113.
28. Lamarche B, Despres JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular study). Am J Cardiol 1995; 75: 1189-1195.
29. Genest JJ, McNamara JR, Ordovas JM, Jenner JL, Silberman SR, Anderson KM. Lipoprotein cholesterol, apolipoprotein AI and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol 1992; 19: 792-802.
30. Feingold KR, Judy K, Shigenaga Lisa G, Chui Moser A, Khovidhunkit W, Grunfeld C. infection and inflammation decrease apolipoprotein M expression. Atherosclerosis 2008; 199(1): 19-26. (Pubitemid 351902196)
31. Ly H, Franconi OL, Fielding CJ. Endotoxin and TNF lead to reduced LCAT activity and decreased hepatic LCAT m RNA levels in Syrian hamsters. J Lipid Res 1995; 36: 1254-1263.
32. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288: 481-487.
33. Denicola A, Radi R. Peroxynitrite and drug-dependent toxicity. Toxicology 2005; 208: 273-288. (Pubitemid 40187337)
34. Rubbo H, Batthyany E, Radi R. Nitric oxide - oxygen radicals interactions in atherosclerosis. Biol Res 2000; 33(2): 167-175.
35. Graham A, Hogg N, Kalyanaraman B, O'Leary V, Darley-Usmar V, Moncada S. Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett 1993; 330: 181-185. (Pubitemid 23265127)
36. Guy RA, Maguire GF, Crandall I, Connelly PW, Kain KC. Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36. Atherosclerosis 2001; 155: 19-28. (Pubitemid 32167120)
37. Podrez EA, Schmitt D, Hoff HF, Hazen SL. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest 1999; 103: 1547-1560.